Preferential CEBP Binding to T:G Mismatches and Increased C-to-T Human Somatic Mutations
Overview
Authors
Affiliations
DNA cytosine methylation in mammals modulates gene expression and chromatin accessibility. It also impacts mutation rates, via spontaneous oxidative deamination of 5-methylcytosine (5mC) to thymine. In most cases the resulting T:G mismatches are repaired, following T excision by one of the thymine DNA glycosylases, TDG or MBD4. We found that C-to-T mutations are enriched in the binding sites of CCAAT/enhancer binding proteins (CEBP). Within a CEBP site, the presence of a T:G mismatch increased CEBPβ binding affinity by a factor of >60 relative to the normal C:G base pair. This enhanced binding to a mismatch inhibits its repair by both TDG and MBD4 in vitro. Furthermore, repair of the deamination product of unmethylated cytosine, which yields a U:G DNA mismatch that is normally repaired via uracil DNA glycosylase, is also inhibited by CEBPβ binding. Passage of a replication fork over either a T:G or U:G mismatch, before repair can occur, results in a C-to-T mutation in one of the daughter duplexes. Our study thus provides a plausible mechanism for accumulation of C-to-T human somatic mutations.
Macphillamy C, Chen T, Hiendleder S, Williams J, Alinejad-Rokny H, Low W Gigascience. 2024; 13.
PMID: 39435573 PMC: 11484048. DOI: 10.1093/gigascience/giae061.
Zhang X, Blumenthal R, Cheng X Nucleic Acids Res. 2024; 52(19):11442-11454.
PMID: 39329271 PMC: 11514455. DOI: 10.1093/nar/gkae832.
Backbone Conformational Equilibrium in Mismatched DNA Correlates with Enzyme Activity.
Westwood M, Pilarski A, JOHNSON C, Mamoud S, Meints G Biochemistry. 2023; 62(19):2816-2827.
PMID: 37699121 PMC: 10552547. DOI: 10.1021/acs.biochem.3c00230.
Yaacov A, Rosenberg S, Simon I Sci Rep. 2023; 13(1):7833.
PMID: 37188696 PMC: 10185532. DOI: 10.1038/s41598-023-34631-9.
Meta-data analysis of kidney stone disease highlights ATP1A1 involvement in renal crystal formation.
Li Y, Lu X, Yu Z, Wang H, Gao B Redox Biol. 2023; 61:102648.
PMID: 36871182 PMC: 10009205. DOI: 10.1016/j.redox.2023.102648.